無輸血醫療的成本效益
經濟效益評估
The cost of blood transfusion in Western Europe as estimated from six studies. （開啟新視窗）
來源: Transfusion 2012;52(9):1983-8.
檢索: PubMed 22313531
DOI碼: 10.1111/j.1537-2995.2011.03532.x
Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. （開啟新視窗）
來源: Ann Surg 2019;269(5):794-804.
檢索: PubMed 30418206
DOI碼: 10.1097/SLA.0000000000003095
Cost estimate of platelet transfusion in the United States for patients with chronic liver disease and associated thrombocytopenia undergoing elective procedures. （開啟新視窗）
來源: J Med Econ 2018;21(8):827-34.
檢索: PubMed 29912593
DOI碼: 10.1080/13696998.2018.1490301
Blood management: a primer for clinicians. （開啟新視窗）
來源: Pharmacotherapy 2007;27(10):1394-411.
檢索: PubMed 17896895
DOI碼: 10.1592/phco.27.10.1394
Peri-operative blood transfusion increases length of hospital stay and number of postoperative complications in non-cardiac surgical patients. （開啟新視窗）
來源: Hong Kong Med J 2010;16(2):116-20.
檢索: PubMed 20354245
Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the premier perspectives database. （開啟新視窗）
來源: Clinicoecon Outcomes Res 2015;7:409-21.
檢索: PubMed 26229495
DOI碼: 10.2147/CEOR.S86369
Estimating the epidemiological and economic impact of implementing preoperative anaemia measures in the German healthcare system: the health economic footprint of patient blood management. （開啟新視窗）
來源: Adv Ther 2020;37(8):3515-36.
檢索: PubMed 32562124
DOI碼: 10.1007/s12325-020-01372-4
Implementation of a patient blood management program based on a low-income country-adapted clinical decision support system. （開啟新視窗）
來源: Hematol Transfus Cell Ther 2022;44(3):374-8.
檢索: PubMed 33741301
DOI碼: 10.1016/j.htct.2020.12.010
Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. （開啟新視窗）
來源: Anesth Analg 2022;135(3):576-85.
檢索: PubMed 35977366
DOI碼: 10.1213/ANE.0000000000006114
Implementing a health system-wide patient blood management program with a clinical community approach. （開啟新視窗）
來源: Anesthesiology 2017;127(5):754-64.
檢索: PubMed 28885446
DOI碼: 10.1097/ALN.0000000000001851
Risk-adjusted clinical outcomes in patients enrolled in a bloodless program. （開啟新視窗）
來源: Transfusion 2014;54(10 Pt 2):2668-77.
檢索: PubMed 24942198
DOI碼: 10.1111/trf.12752
The ONTraC Ontario program in blood conservation. （開啟新視窗）
來源: Transfus Apher Sci 2014;50(1):32-6.
檢索: PubMed 24388485
DOI碼: 10.1016/j.transci.2013.12.010
Restrictive blood transfusion practices are associated with improved patient outcomes. （開啟新視窗）
來源: Transfusion 2014;54(10 Pt 2):2753-9.
檢索: PubMed 24995770
DOI碼: 10.1111/trf.12723
The contemporary economics of transfusions. （開啟新視窗）
來源: In: Spiess BD, Spence RK, Shander A, eds. Perioperative Transfusion Medicine. Second edition. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 13-38.
檢索: ISBN 0-7817-3755-9
Improving red cell transfusion in the elective surgical setting: an improvement collaborative with evaluation. （開啟新視窗）
來源: Vox Sang 2015;108(4):393-402.
檢索: PubMed 25753648
DOI碼: 10.1111/vox.12237
Economic considerations on transfusion medicine and patient blood management. （開啟新視窗）
來源: Best Pract Res Clin Anaesthesiol 2013;27(1):59-68.
檢索: PubMed 23590916
DOI碼: 10.1016/j.bpa.2013.02.001
Activity-based cost of platelet transfusions in medical and surgical inpatients at a US hospital. （開啟新視窗）
來源: Vox Sang 2021;116(9):998-1004.
檢索: PubMed 33772793
DOI碼: 10.1111/vox.13095
The cost of one unit blood transfusion components and cost-effectiveness analysis results of transfusion improvement program. （開啟新視窗）
來源: Turk Gogus Kalp Damar Cerrahisi Derg 2021;29(2):150-7.
檢索: PubMed 34104508
DOI碼: 10.5606/tgkdc.dergisi.2021.20886
Transfusing wisely: clinical decision support improves blood transfusion practices. （開啟新視窗）
來源: Jt Comm J Qual Patient Saf 2017;43(8):389-95.
檢索: PubMed 28738984
DOI碼: 10.1016/j.jcjq.2017.04.003
Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. （開啟新視窗）
來源: Anaesthesia 2019;74(12):1534-41.
檢索: PubMed 31448406
DOI碼: 10.1111/anae.14816
A model-based cost-effectiveness analysis of Patient Blood Management. （開啟新視窗）
來源: Blood Transfus 2019;17(1):16-26.
檢索: PubMed 29517965
DOI碼: 10.2450/2018.0213-17
Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. （開啟新視窗）
來源: Transfusion 2017;57(6):1347-58.
檢索: PubMed 28150313
DOI碼: 10.1111/trf.14006
Clinical, economical and safety impact of ferric carboxymaltose use in Patient Blood Management programme in Portuguese National Health Service hospitals. （開啟新視窗）
來源: Sci Rep 2022;12(1):19335.
檢索: PubMed 36369296
DOI碼: 10.1038/s41598-022-21929-3
Risks, benefits, alternatives and indications of allogenic blood transfusions. （開啟新視窗）
來源: Minerva Anestesiol 2006;72(5):283-98.
檢索: PubMed 16675937
Adequacy of physician documentation and correlation with assessment of transfusion appropriateness: a follow-up study in the setting of prospective audits and patient blood management. （開啟新視窗）
來源: Transfusion 2017;57(2):367-75.
檢索: PubMed 27873340
DOI碼: 10.1111/trf.13917
The costs of producing a unit of blood in Zimbabwe. （開啟新視窗）
來源: Transfusion 2016;56(3):628-36.
檢索: PubMed 26598799
DOI碼: 10.1111/trf.13405
Evaluation of a multilevel laboratory stewardship intervention targeted to cardiac and thoracic surgical services at an academic medical center. （開啟新視窗）
來源: Arch Pathol Lab Med 2023;147(8):957-63.
檢索: PubMed 36287195
DOI碼: doi: 10.5858/arpa.2021-0593-OA.
A contemporary analysis of phlebotomy and iatrogenic anemia development throughout hospitalization in critically ill adults. （開啟新視窗）
來源: Anesth Analg 2022;135(3):501-10.
檢索: PubMed 35977360
DOI碼: 10.1213/ANE.0000000000006127
The cost of blood: a study of the total cost of red blood cell transfusion in patients with β-thalassemia using time-driven activity-based costing. （開啟新視窗）
來源: Transfusion 2019;59(11):3386-95.
檢索: PubMed 31664712
DOI碼: 10.1111/trf.15558
Associations between preoperative anaemia and hospital costs following major abdominal surgery: cohort study. （開啟新視窗）
來源: BJS Open 2021;5(2):zraa070.
檢索: PubMed 33834189
DOI碼: 10.1093/bjsopen/zraa070
Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 healthcare cost and utilization project nationwide inpatient sample database. （開啟新視窗）
來源: Am J Med Qual 2010;25(4):289-96.
檢索: PubMed 20530223
DOI碼: 10.1177/1062860610366159
ONTraC: A 20-year history of a successfully coordinated provincewide Patient Blood Management Program: lessons learned and goals achieved. （開啟新視窗）
來源: Anesth Analg 2022;135(3):448-58.
檢索: PubMed 35977355
DOI碼: 10.1213/ANE.0000000000006065
Effective reduction of blood product use in a community teaching hospital: when less is more. （開啟新視窗）
來源: Am J Med 2013;126(10):894-902.
檢索: PubMed 24054957
DOI碼: 10.1016/j.amjmed.2013.06.013
Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. （開啟新視窗）
來源: JAMA 2014;311(13):1317-26.
檢索: PubMed 24691607
DOI碼: 10.1001/jama.2014.2726
Perioperative inappropriate red blood cell transfusions significantly increase total costs in elective surgical patients, representing an important economic burden for hospitals. （開啟新視窗）
來源: Front Med (Lausanne) 2022;9:956128.
檢索: PubMed 36111110
DOI碼: 10.3389/fmed.2022.956128
Activity-based costs of blood transfusions in surgical patients at four hospitals. （開啟新視窗）
來源: Transfusion 2010;50(4):753-65.
檢索: PubMed 20003061
DOI碼: 10.1111/j.1537-2995.2009.02518.x
Activity-based costs of plasma transfusions in medical and surgical inpatients at a US hospital. （開啟新視窗）
來源: Vox Sang 2016;111(1):55-61.
檢索: PubMed 26919686
DOI碼: 10.1111/vox.12386
Financial and clinical outcomes associated with surgical bleeding complications. （開啟新視窗）
來源: Surgery 2007;142(4 Suppl):S20-5.
檢索: PubMed 18019945
Accurate costs of blood transfusion: a microcosting of administering blood products in the United Kingdom National Health Service. （開啟新視窗）
來源: Transfusion 2018;58(4):846-53.
檢索: PubMed 29380872
DOI碼: 10.1111/trf.14493
Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. （開啟新視窗）
來源: BMC Health Serv Res 2011;11:135.
檢索: PubMed 21627788
DOI碼: 10.1186/1472-6963-11-135
Cost-effectiveness and budget impact of comprehensive anemia management, the first pillar of patient blood management, on the Turkish healthcare system. （開啟新視窗）
來源: Clinicoecon Outcomes Res 2022;14:415-26.
檢索: PubMed 35669886
DOI碼: 10.2147/CEOR.S360944
Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services. （開啟新視窗）
來源: Appl Health Econ Health Policy 2011;9(1):29-37.
檢索: PubMed 21174480
DOI碼: 10.2165/11530740-000000000-00000
Increased hospital costs associated with red blood cell transfusion. （開啟新視窗）
來源: Transfusion 2015;55(5):1082-9.
檢索: PubMed 25488623
DOI碼: 10.1111/trf.12958
Associations of a preoperative anemia and suboptimal iron stores screening and management clinic in colorectal surgery with hospital cost, reimbursement, and length of stay: a net cost analysis. （開啟新視窗）
來源: Anesth Analg 2021;132(2):344-52.
檢索: PubMed 33105276
DOI碼: 10.1213/ANE.0000000000005241
Implementation of a comprehensive patient blood management program for hospitalized patients at a large united states medical center. （開啟新視窗）
來源: Mayo Clin Proc. 2021;96(12):2980-90.
檢索: PubMed 34736775
DOI碼: 10.1016/j.mayocp.2021.07.017